Moreover, TAMs underwent a pro-inflammatory shift following anti-PSGL-1 antagonist antibody treatment in a humanized melanoma model, and a comparable phenomenon was observed in ex vivo tumor cultures from patients [57]. The gene discussed is SELPLG; the disease is melanoma.